Literature DB >> 33579203

Polygenic risk score is a predictor of adenomatous polyps at screening colonoscopy.

Michael J Northcutt1, Zhuqing Shi2, Michael Zijlstra3, Ayush Shah3, Siqun Zheng2, Eugene F Yen4, Omar Khan4, Mohammad Imran Beig5, Polina Imas5, Adam Vanderloo5, Obaid Ansari5, Jianfeng Xu2, Jay L Goldstein4,6.   

Abstract

BACKGROUND: Single nucleotide polymorphism (SNP)-based polygenic risk scoring is predictive of colorectal cancer (CRC) risk. However, few studies have investigated the association of genetic risk score (GRS) with detection of adenomatous polyps at screening colonoscopy.
METHODS: We randomly selected 1769 Caucasian subjects who underwent screening colonoscopy from the Genomic Health Initiative (GHI), a biobank of NorthShore University HealthSystem. Outcomes from initial screening colonoscopy were recorded. Twenty-two CRC risk-associated SNPs were obtained from the Affymetrix™ SNP array and used to calculate an odds ratio (OR)-weighted and population-standardized GRS. Subjects with GRS of < 0.5, 0.5-1.5, and > 1.5 were categorized as low, average and elevated risk.
RESULTS: Among 1,769 subjects, 520 (29%) had 1 or more adenomatous polyps. GRS was significantly higher in subjects with adenomatous polyps than those without; mean (95% confidence interval) was 1.02 (1.00-1.05) and 0.97 (0.95-0.99), respectively, p < 0.001. The association remained significant after adjusting for age, gender, body mass index, and family history, p < 0.001. The detection rate of adenomatous polyps was 10.8%, 29.0% and 39.7% in subjects with low, average and elevated GRS, respectively, p-trend < 0.001. Higher GRS was also associated with early age diagnosis of adenomatous polyps, p < 0.001. In contrast, positive family history was not associated with risk and age of adenomatous polyps.
CONCLUSIONS: GRS was significantly associated with adenomatous polyps in subjects undergoing screening colonoscopy. This result may help in stratifying average risk patients and facilitating personalized colonoscopy screening strategies.

Entities:  

Keywords:  Adenomatous polyps; Colonoscopy; Colorectal cancer; GRS; Polygenic risk score; Screening

Mesh:

Year:  2021        PMID: 33579203      PMCID: PMC7881602          DOI: 10.1186/s12876-021-01645-4

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  28 in total

1.  A model to determine colorectal cancer risk using common genetic susceptibility loci.

Authors:  Li Hsu; Jihyoun Jeon; Hermann Brenner; Stephen B Gruber; Robert E Schoen; Sonja I Berndt; Andrew T Chan; Jenny Chang-Claude; Mengmeng Du; Jian Gong; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; Carolyn M Hutter; Yi Lin; Reiko Nishihara; Shuji Ogino; Ross L Prentice; Fredrick R Schumacher; Daniela Seminara; Martha L Slattery; Duncan C Thomas; Mark Thornquist; Polly A Newcomb; John D Potter; Yingye Zheng; Emily White; Ulrike Peters
Journal:  Gastroenterology       Date:  2015-02-13       Impact factor: 22.682

2.  Association of genetic variants for colorectal cancer differs by subtypes of polyps in the colorectum.

Authors:  Ben Zhang; Martha J Shrubsole; Guoliang Li; Qiuyin Cai; Todd Edwards; Walter E Smalley; Reid M Ness; Wei Zheng
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

Review 3.  Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians.

Authors:  Amir Qaseem; Carolyn J Crandall; Reem A Mustafa; Lauri A Hicks; Timothy J Wilt; Mary Ann Forciea; Nick Fitterman; Carrie A Horwitch; Devan Kansagara; Michael Maroto; Robert M McLean; Jairo Roa; Janice Tufte
Journal:  Ann Intern Med       Date:  2019-11-05       Impact factor: 25.391

4.  Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson
Journal:  Gastrointest Endosc       Date:  2017-06-06       Impact factor: 9.427

Review 5.  Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Authors:  Nadine Tung; Susan M Domchek; Zsofia Stadler; Katherine L Nathanson; Fergus Couch; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  Nat Rev Clin Oncol       Date:  2016-06-14       Impact factor: 66.675

6.  American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].

Authors:  Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

7.  Implications of polygenic risk for personalised colorectal cancer screening.

Authors:  M J E Frampton; P Law; K Litchfield; E J Morris; D Kerr; C Turnbull; I P Tomlinson; R S Houlston
Journal:  Ann Oncol       Date:  2015-11-16       Impact factor: 32.976

8.  Long-term colorectal-cancer incidence and mortality after lower endoscopy.

Authors:  Reiko Nishihara; Kana Wu; Paul Lochhead; Teppei Morikawa; Xiaoyun Liao; Zhi Rong Qian; Kentaro Inamura; Sun A Kim; Aya Kuchiba; Mai Yamauchi; Yu Imamura; Walter C Willett; Bernard A Rosner; Charles S Fuchs; Edward Giovannucci; Shuji Ogino; Andrew T Chan
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

9.  Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.

Authors:  Nicola Whiffin; Fay J Hosking; Susan M Farrington; Claire Palles; Sara E Dobbins; Lina Zgaga; Amy Lloyd; Ben Kinnersley; Maggie Gorman; Albert Tenesa; Peter Broderick; Yufei Wang; Ella Barclay; Caroline Hayward; Lynn Martin; Daniel D Buchanan; Aung Ko Win; John Hopper; Mark Jenkins; Noralane M Lindor; Polly A Newcomb; Steve Gallinger; David Conti; Fred Schumacher; Graham Casey; Tao Liu; Harry Campbell; Annika Lindblom; Richard S Houlston; Ian P Tomlinson; Malcolm G Dunlop
Journal:  Hum Mol Genet       Date:  2014-04-15       Impact factor: 6.150

10.  Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.

Authors:  Wei-Hua Jia; Ben Zhang; Keitaro Matsuo; Aesun Shin; Yong-Bing Xiang; Sun Ha Jee; Dong-Hyun Kim; Zefang Ren; Qiuyin Cai; Jirong Long; Jiajun Shi; Wanqing Wen; Gong Yang; Ryan J Delahanty; Bu-Tian Ji; Zhi-Zhong Pan; Fumihiko Matsuda; Yu-Tang Gao; Jae Hwan Oh; Yoon-Ok Ahn; Eun Jung Park; Hong-Lan Li; Ji Won Park; Jaeseong Jo; Jin-Young Jeong; Satoyo Hosono; Graham Casey; Ulrike Peters; Xiao-Ou Shu; Yi-Xin Zeng; Wei Zheng
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330

View more
  1 in total

Review 1.  Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients' Stratification.

Authors:  Elena Ionica; Gisela Gaina; Mihaela Tica; Mariana-Carmen Chifiriuc; Gratiela Gradisteanu-Pircalabioru
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.